Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 495

1.

Insulin allergy brought out 8 years after starting insulin therapy in a subject with type 1 diabetes mellitus.

Kimura T, Fushimi Y, Hayashi H, Tatsumi F, Kanda-Kimura Y, Shimoda M, Hirukawa H, Sanada J, Obata A, Kohara K, Nakanishi S, Mune T, Kaku K, Kaneto H.

Acta Diabetol. 2020 Feb 20. doi: 10.1007/s00592-020-01499-4. [Epub ahead of print] No abstract available.

PMID:
32078040
2.
3.

Practical application of short-term intensive insulin therapy based on the concept of "treat to target" to reduce hypoglycaemia in routine clinical site.

Nakashima K, Okamura N, Sanefuji H, Kaneto H.

Sci Rep. 2020 Jan 31;10(1):1552. doi: 10.1038/s41598-020-58574-7.

4.

Alteration of ACTH and Cortisol Levels After Estradiol Valerate Treatment in a Male Subject With Gender Dysphoria: A Case Report.

Anno T, Kawasaki F, Shigemoto R, Irie S, Mune T, Kaku K, Kaneto H.

Front Endocrinol (Lausanne). 2019 Nov 5;10:751. doi: 10.3389/fendo.2019.00751. eCollection 2019.

5.

Impact of physical activity and sedentary time on glycated hemoglobin levels and body composition: Cross-sectional study using outpatient clinical data of Japanese patients with type 2 diabetes.

Nakanishi S, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Okauchi S, Katakura Y, Sanada J, Fushimi Y, Nishioka M, Kan Y, Tomita-Mizoguchi A, Isobe H, Iwamoto H, Takahashi K, Mune T, Kaku K, Kaneto H.

J Diabetes Investig. 2019 Nov 22. doi: 10.1111/jdi.13185. [Epub ahead of print]

6.

Correction to: Vascular endothelial PDPK1 plays a pivotal role in the maintenance of pancreatic beta cell mass and function in adult male mice.

Obata A, Kimura T, Obata Y, Shimoda M, Kinoshita T, Kohara K, Okauchi S, Hirukawa H, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H.

Diabetologia. 2019 Dec;62(12):2375. doi: 10.1007/s00125-019-04982-y.

7.

Severe hypertriglyceridemia in a subject with disturbed life style and poor glycemic control without recurrence of acute pancreatitis: a case report.

Irie S, Anno T, Kawasaki F, Shigemoto R, Nakanishi S, Kaku K, Kaneto H.

BMC Endocr Disord. 2019 Aug 30;19(1):92. doi: 10.1186/s12902-019-0425-9.

8.

Decreased plasma aldosterone levels in patients with type 2diabetes mellitus: A possible pitfall in diagnosis of primary aldosteronism.

Anno T, Mune T, Takai M, Kimura T, Hirukawa H, Kawasaki F, Okimoto N, Kaku K, Kaneto H.

Diabetes Metab. 2019 Sep;45(4):399-400. doi: 10.1016/j.diabet.2018.06.003. Epub 2018 Jun 19. No abstract available.

PMID:
31422796
9.

Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: A retrospective longitudinal study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus.

Nakanishi S, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Okauchi S, Katakura Y, Sanada J, Fushimi Y, Kan Y, Tomita A, Isobe H, Iwamoto H, Takahashi K, Mune T, Kaku K, Kaneto H.

Diabetes Res Clin Pract. 2019 Sep;155:107807. doi: 10.1016/j.diabres.2019.107807. Epub 2019 Aug 5.

10.

Dramatic Improvement of Glycemic Control by Promptly Starting Steroid Therapy at an Early Stage of Autoimmune Pancreatitis in a Subject with Type 2 Diabetes.

Irie S, Anno T, Uji E, Nakamura J, Kawasaki F, Kawamoto H, Kaku K, Kaneto H.

Intern Med. 2019 Dec 1;58(23):3427-3431. doi: 10.2169/internalmedicine.3198-19. Epub 2019 Jul 31.

11.

Marked elevation of plasma procalcitonin levels in patients with diabetic ketoacidosis: A possible useful diagnostic biomarker.

Anno T, Shigemoto R, Kawasaki F, Irie S, Miyashita N, Kaku K, Kaneto H.

Diabetes Metab. 2019 Jun 4. pii: S1262-3636(19)30089-8. doi: 10.1016/j.diabet.2019.05.006. [Epub ahead of print] No abstract available.

PMID:
31178365
12.

Vascular endothelial PDPK1 plays a pivotal role in the maintenance of pancreatic beta cell mass and function in adult male mice.

Obata A, Kimura T, Obata Y, Shimoda M, Kinoshita T, Kohara K, Okauchi S, Hirukawa H, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H.

Diabetologia. 2019 Jul;62(7):1225-1236. doi: 10.1007/s00125-019-4878-1. Epub 2019 May 4. Erratum in: Diabetologia. 2019 Dec;62(12):2375.

13.

Idiopathic and isolated adrenocorticotropic hormone deficiency presenting as continuous epigastric discomfort without symptoms of hypoglycemia: a case report.

Okauchi S, Tatsumi F, Kan Y, Horiya M, Mizoguchi A, Fushimi Y, Sanada J, Nishioka M, Shimoda M, Kohara K, Nakanishi S, Kaku K, Mune T, Kaneto H.

J Med Case Rep. 2019 Apr 30;13(1):113. doi: 10.1186/s13256-019-2050-7.

14.

Eicosapentaenoic acid/arachidonic acid ratio and weight loss during hospitalization for glycemic control among overweight Japanese patients with type 2 diabetes: a retrospective observational study.

Nakanishi S, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Okauchi S, Kinoshita T, Sanada J, Fushimi Y, Nishioka M, Kan Y, Tomita A, Mashiko A, Horiya M, Iwamoto Y, Mune T, Kaku K, Kaneto H.

Lipids Health Dis. 2019 Jan 31;18(1):36. doi: 10.1186/s12944-019-0983-x.

15.

Acute exacerbation of chronic osteomyelitis triggered by aggravation of type 2 diabetes mellitus: a case report.

Irie S, Anno T, Kawasaki F, Shigemoto R, Kaneto H, Kaku K, Okimoto N.

J Med Case Rep. 2019 Jan 7;13(1):7. doi: 10.1186/s13256-018-1954-y.

16.

Administration of RAS Inhibitor before the Onset of Diabetic Nephropathy Counteracts the Adverse Effect of Chronic Hyperglycemia and Reduces the Augmentation of Urinary Albumin Excretion: A Retrospective Clinical Study.

Hirukawa H, Kamei S, Kimura T, Obata A, Kohara K, Tatsumi F, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H.

J Diabetes Res. 2018 Nov 7;2018:9435401. doi: 10.1155/2018/9435401. eCollection 2018.

17.

Pancreatic islet-autonomous insulin and smoothened-mediated signalling modulate identity changes of glucagon+ α-cells.

Cigliola V, Ghila L, Thorel F, van Gurp L, Baronnier D, Oropeza D, Gupta S, Miyatsuka T, Kaneto H, Magnuson MA, Osipovich AB, Sander M, Wright CEV, Thomas MK, Furuyama K, Chera S, Herrera PL.

Nat Cell Biol. 2018 Nov;20(11):1267-1277. doi: 10.1038/s41556-018-0216-y. Epub 2018 Oct 22.

18.

Suppression of free fatty acid receptor 1 expression in pancreatic β-cells in obese type 2 diabetic db/db mice: a potential role of pancreatic and duodenal homeobox factor 1.

Kohara K, Obata A, Kimura T, Shimoda M, Moriuchi S, Okauchi S, Hirukawa H, Mune T, Kaku K, Kaneto H.

Endocr J. 2019 Jan 28;66(1):43-50. doi: 10.1507/endocrj.EJ18-0203. Epub 2018 Oct 17.

19.

A rare case of large pyosalpinx in an elderly patient with well-controlled type 2 diabetes mellitus: a case report.

Hida M, Anno T, Kawasaki F, Kaneto H, Kaku K, Okimoto N.

J Med Case Rep. 2018 Oct 6;12(1):286. doi: 10.1186/s13256-018-1841-6.

20.

Association of the Glycemic Fluctuation as well as Glycemic Control with the Pancreatic β-cell Function in Japanese Subjects with Type 2 Diabetes Mellitus.

Takai M, Anno T, Kawasaki F, Kimura T, Hirukawa H, Mune T, Okimoto N, Kaku K, Kaneto H.

Intern Med. 2019 Jan 15;58(2):167-173. doi: 10.2169/internalmedicine.1053-18. Epub 2018 Aug 24.

21.

Verification of Kumamoto Declaration 2013 and Glycemic Targets for Elderly Patients with Diabetes in Japan for prevention of diabetic complications: A retrospective longitudinal study using outpatient clinical data.

Nakanishi S, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Kimura T, Okauchi S, Kinoshita T, Sanada J, Fushimi Y, Nishioka M, Mizoguchi A, Mune T, Kaku K, Kaneto H.

J Diabetes Investig. 2019 Mar;10(2):290-301. doi: 10.1111/jdi.12909. Epub 2018 Sep 10.

22.

Down-regulation of vascular GLP-1 receptor expression in human subjects with obesity.

Kimura T, Obata A, Shimoda M, Shimizu I, da Silva Xavier G, Okauchi S, Hirukawa H, Kohara K, Mune T, Moriuchi S, Hiraoka A, Tamura K, Chikazawa G, Ishida A, Yoshitaka H, Rutter GA, Kaku K, Kaneto H.

Sci Rep. 2018 Jul 13;8(1):10644. doi: 10.1038/s41598-018-28849-1.

23.

There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study.

Kinoshita T, Shimoda M, Sanada J, Fushimi Y, Hirata Y, Irie S, Obata A, Kimura T, Hirukawa H, Kohara K, Tatsumi F, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H.

Diabetes Ther. 2018 Aug;9(4):1569-1580. doi: 10.1007/s13300-018-0447-8. Epub 2018 Jun 21.

24.

Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long-term therapy for chronic inflammatory demyelinating polyneuropathy.

Shigemoto R, Anno T, Ohnuki E, Kosaka S, Okimoto N, Kaku K, Kaneto H.

J Diabetes Investig. 2018 Nov;9(6):1378-1380. doi: 10.1111/jdi.12796. Epub 2018 Jun 15. No abstract available.

25.

Onset of type 1 diabetes mellitus and heparin-induced thrombocytopenia in a patient with Basedow's disease and idiopathic thrombocytopenic purpura: Novel combination as autoimmune polyglandular syndrome.

Kinoshita T, Kamei S, Nakamura Y, Shimoda M, Anno T, Obata A, Kimura T, Hirukawa H, Tatsumi F, Kohara K, Nakanishi S, Mune T, Kaku K, Kaneto H.

J Diabetes Investig. 2018 Nov;9(6):1381-1382. doi: 10.1111/jdi.12811. Epub 2018 Jun 15. No abstract available.

26.

Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic β-cells in db/db mice: The earlier and longer, the better.

Kimura T, Obata A, Shimoda M, Okauchi S, Kanda-Kimura Y, Nogami Y, Moriuchi S, Hirukawa H, Kohara K, Nakanishi S, Mune T, Kaku K, Kaneto H.

Diabetes Obes Metab. 2018 Oct;20(10):2442-2457. doi: 10.1111/dom.13400. Epub 2018 Jul 5.

PMID:
29873444
27.

MicroRNA-31 reflects IL-6 expression in cancer tissue and is related with poor prognosis in bile duct cancer.

Ishigami K, Nosho K, Koide H, Kanno S, Mitsuhashi K, Igarashi H, Shitani M, Motoya M, Kimura Y, Hasegawa T, Kaneto H, Takemasa I, Suzuki H, Nakase H.

Carcinogenesis. 2018 Sep 21;39(9):1127-1134. doi: 10.1093/carcin/bgy075.

PMID:
29860474
28.

Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis.

Nakanishi S, Iwamoto M, Kamei S, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Kimura T, Kinoshita T, Irie S, Sanada J, Fushimi Y, Nishioka M, Mizoguchi A, Kameyama M, Mune T, Kaku K, Kaneto H.

Intern Med. 2018;57(10):1381-1389. doi: 10.2169/internalmedicine.9334-17. Epub 2018 May 15.

29.

Fulminant Type 1 Diabetes Mellitus Complicated with a Life-threatening Electrolyte Abnormality and Abnormal Electrocardiogram Findings.

Kinoshita T, Kaneto H, Kawasaki F, Anno T, Kurihara T, Yamada H, Oshiro Y, Miyashita N, Okimoto N, Kaku K.

Intern Med. 2018 Sep 15;57(18):2685-2688. doi: 10.2169/internalmedicine.0680-17. Epub 2018 Apr 27.

30.

Drug fever and acute inflammation from hypercytokinemia triggered by dipeptidyl peptidase-4 inhibitor vildagliptin.

Anno T, Kaneto H, Kawasaki F, Shigemoto R, Aoyama Y, Kaku K, Okimoto N.

J Diabetes Investig. 2019 Jan;10(1):182-185. doi: 10.1111/jdi.12847. Epub 2018 May 2.

31.

Saibokuto as a Possible Therapy for Type B Insulin Resistance Syndrome: The Disappearance of Anti-insulin Receptor Antibody and a Marked Amelioration of Glycemic Control by Saibokuto Treatment.

Kawasaki F, Anno T, Takai M, Irie S, Kaneto H, Kaku K, Okimoto N.

Intern Med. 2018 Aug 15;57(16):2359-2363. doi: 10.2169/internalmedicine.0523-17. Epub 2018 Mar 9.

32.

Effect of mild exercise on glycemic and bodyweight control in Japanese type 2 diabetes patients: A retrospective analysis.

Nakanishi S, Iwamoto M, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Okauchi S, Kinoshita T, Sanada J, Fushimi Y, Nishioka M, Mizoguchi A, Kameyama M, Mune T, Kaku K, Kaneto H.

J Diabetes Investig. 2019 Jan;10(1):104-107. doi: 10.1111/jdi.12832. Epub 2018 Mar 30.

33.

Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure.

Kimura T, Obata A, Shimoda M, Hirukawa H, Kanda-Kimura Y, Nogami Y, Kohara K, Nakanishi S, Mune T, Kaku K, Kaneto H.

Diabetes Metab. 2018 Jun;44(3):250-260. doi: 10.1016/j.diabet.2017.10.007. Epub 2018 Feb 6.

PMID:
29525225
34.

Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus.

Kamei S, Iwamoto M, Kameyama M, Shimoda M, Kinoshita T, Obata A, Kimura T, Hirukawa H, Tatsumi F, Kohara K, Nakanishi S, Mune T, Kaku K, Kaneto H.

J Diabetes Res. 2018 Jan 8;2018:6470137. doi: 10.1155/2018/6470137. eCollection 2018.

35.

Hypoinsulinemic hypoglycemia triggered by liver injury in elderly subjects with low body weight: case reports.

Anno T, Kaneto H, Shigemoto R, Kawasaki F, Kawai Y, Urata N, Kawamoto H, Kaku K, Okimoto N.

Endocrinol Diabetes Metab Case Rep. 2018 Feb 23;2018. pii: 17-0155. doi: 10.1530/EDM-17-0155. eCollection 2018.

36.
37.

Can Trainees Safely Perform Endoscopic Treatments for Common Bile Duct Stones? A Single-center Retrospective Study.

Iida T, Kaneto H, Wagatsuma K, Sasaki H, Naganawa Y, Nakagaki S, Satoh S, Shimizu H, Nakase H.

Intern Med. 2018 Apr 1;57(7):923-928. doi: 10.2169/internalmedicine.9737-17. Epub 2018 Feb 9.

38.

Hepatic Gi signaling regulates whole-body glucose homeostasis.

Rossi M, Zhu L, McMillin SM, Pydi SP, Jain S, Wang L, Cui Y, Lee RJ, Cohen AH, Kaneto H, Birnbaum MJ, Ma Y, Rotman Y, Liu J, Cyphert TJ, Finkel T, McGuinness OP, Wess J.

J Clin Invest. 2018 Feb 1;128(2):746-759. doi: 10.1172/JCI94505. Epub 2018 Jan 16.

39.

Aggravation of type 2 diabetes mellitus triggered by acute exacerbation of chronic thyroiditis (Hashimoto's disease).

Takai M, Anno T, Kawasaki F, Shigemoto R, Kan Y, Kaneto H, Kaku K, Okimoto N.

J Diabetes Investig. 2018 Jan;9(1):226-227. doi: 10.1111/jdi.12648. No abstract available.

40.

Efficacy and safety of endoscopic procedures for common bile duct stones in patients aged 85 years or older: A retrospective study.

Iida T, Kaneto H, Wagatsuma K, Sasaki H, Naganawa Y, Nakagaki S, Satoh S, Shimizu H, Nakase H.

PLoS One. 2018 Jan 3;13(1):e0190665. doi: 10.1371/journal.pone.0190665. eCollection 2018.

41.

Author's Reply.

Iida T, Kaneto H, Nakase H.

Intest Res. 2017 Oct;15(4):554. doi: 10.5217/ir.2017.15.4.554. Epub 2017 Oct 23. No abstract available.

42.

Switching from low-dose thiazide diuretics to sodium-glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension.

Kimura T, Sanada J, Shimoda M, Hirukawa H, Fushimi Y, Nishioka M, Kinoshita T, Okauchi S, Obata A, Kohara K, Tatsumi F, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H.

J Diabetes Investig. 2018 Jul;9(4):875-881. doi: 10.1111/jdi.12774. Epub 2017 Dec 4.

43.

Non-clostridial gas gangrene in a patient with poorly controlled type 2 diabetes mellitus on hemodialysis.

Shigemoto R, Anno T, Kawasaki F, Irie S, Yamamoto M, Tokuoka S, Kaneto H, Kaku K, Okimoto N.

Acta Diabetol. 2018 Jan;55(1):99-101. doi: 10.1007/s00592-017-1038-2. Epub 2017 Sep 5. No abstract available.

44.

Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.

Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ohashi M, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I; UTOPIA study investigators.

Diabetes Ther. 2017 Oct;8(5):999-1013. doi: 10.1007/s13300-017-0292-1. Epub 2017 Sep 1.

45.

Decreased glucagon-like peptide 1 receptor expression in endothelial and smooth muscle cells in diabetic db/db mice: TCF7L2 is a possible regulator of the vascular glucagon-like peptide 1 receptor.

Kimura T, Obata A, Shimoda M, Okauchi S, Hirukawa H, Kohara K, Kinoshita T, Nogami Y, Nakanishi S, Mune T, Kaku K, Kaneto H.

Diab Vasc Dis Res. 2017 Nov;14(6):540-548. doi: 10.1177/1479164117725898. Epub 2017 Aug 23.

PMID:
28830217
46.

Werner Syndrome and Diabetes Mellitus Accompanied by Adrenal Cortex Cancer.

Nishioka M, Kamei S, Kinoshita T, Sanada J, Fushimi Y, Irie S, Hirata Y, Tanabe A, Hirukawa H, Kimura T, Obata A, Tatsumi F, Kohara K, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H.

Intern Med. 2017;56(15):1987-1992. doi: 10.2169/internalmedicine.56.8231. Epub 2017 Aug 1.

47.

Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes Mellitus.

Shimoda M, Miyoshi-Takai M, Irie S, Tanabe A, Obata A, Okauchi S, Hirukawa H, Kimura T, Kohara K, Kamei S, Mune T, Kaku K, Kaneto H.

J Diabetes Res. 2017;2017:5856475. doi: 10.1155/2017/5856475. Epub 2017 May 25.

48.

Hypoglycemic Coma Induced by the Use of Succinic Acid Cibenzoline in Frail Late-stage Elderly Subjects.

Hirata Y, Kamei S, Tatsumi F, Shimoda M, Tanabe A, Sanada J, Fushimi Y, Irie S, Mune T, Kaku K, Kaneto H.

Intern Med. 2017;56(12):1527-1529. doi: 10.2169/internalmedicine.56.8120. Epub 2017 Jun 15.

49.

Clinical outcomes of sigmoid colon volvulus: identification of the factors associated with successful endoscopic detorsion.

Iida T, Nakagaki S, Satoh S, Shimizu H, Kaneto H, Nakase H.

Intest Res. 2017 Apr;15(2):215-220. doi: 10.5217/ir.2017.15.2.215. Epub 2017 Apr 27.

50.

Advanced breast cancer in a relatively young man with severe obesity and type 2 diabetes mellitus.

Obata A, Okauchi S, Kimura T, Hirukawa H, Tanabe A, Kinoshita T, Kohara K, Tatsumi F, Shimoda M, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H.

J Diabetes Investig. 2017 May;8(3):395-396. doi: 10.1111/jdi.12570.

Supplemental Content

Loading ...
Support Center